Skip to main content

Table 2 Multivariate analysis

From: Renin-angiotensin-aldosterone system blockers after KDIGO stage 3 acute kidney injury: use and impact on 2-year mortality in the AKIKI trial

Variable

OR

95%CI

p

Age

1.02

[1.00–1.05]

0.04

MacCabe

3.10

[1.64–5.87]

< 0.001

SAPS3

1.04

[1.02–1.07]

< 0.01

CKD

1.99

[0.77–4.89]

0.14

Congestive heart failure

2.12

[0.66–6.43]

0.19

History of acute stroke

1.91

[0.80–4.38]

0.13

ACEi/ARB at ICU discharge

1.71

[0.71–3.90]

0.21

  1. CKD chronic kidney disease